INTRODUCTION
Many skin conditions are mediated by histamine, such as urticaria (physical and immunomediated) angioedema and papular urticaria, supporting the frequent use of type I histamine receptor blockers (AH) in dermatology. 1, 2 Urticaria is the main histamine-mediated condition in dermatology; it is common and affects patient's quality of life. 3 Its prevalence is estimated in 1-1.5%, and up to 10-15% of the population will have one episode sometime in their life. 4, 5 The main effector cell in the physiopathology of most causes of urticaria is the mast cell, that releases mediators such as histamine, inflammatory cytokines, chemokines, leukotrienes, prostaglandins and platelet-activating factor upon degranulation.
These mediators are responsible for vasodilation, sensory activation, plasma leakage and recruitment of cells for the site of these lesions. 6 AH show good absorption when administered orally and, therefore, are capable of reaching effective plasma levels in less than two hours after intake (Table 1) . Most are metabolized in the liver and excreted by the kidneys. They are divided into first and second (or more) generation AH. The tests were performed after two hours of intake of dexchlorpheniramine, hydroxyzine, levocetirizine, fexofenadine, cetirizine, loratadine, ebastine, desloratadine, epinastine and rupatadine, as well as generics of loratadine, cetirizine and fexofenadine. results: All antihistamines presented a reduction in the wheal compared to the control (p <0.02), as well as in the flare, except for rupatadine (p = 0.70). In the internal comparison, cetirizine, fexofenadine, epinastine, levocetirizine, dexchlorpheniramine and hydroxyzine were the most potent, with no difference between them (p > 0.1). As for halo, cetirizine, epinastine, hydroxyzine and fexofenadine were the most potent, with no difference between them (p > 0.1). The most common adverse effect was drowsiness, which was more prevalent among first-generation drugs (p < 0.01). Generic loratadine, fexofenadine and cetirizine halos were higher than their controls (p <0.03).. 1 On the other hand, second and third generation AH, besides more potent and longer lasting, have few adverse effects because the brain-blood barrier is less permeable to them, and they have a high affinity to H1 receptors. 7 There are no studies in Brazil comparing the efficacy to histamine challenge and tolerability of commercial AH.
The epicutaneous histamine test allows for a comparison of the efficacy between drugs regarding the blockage to vascular permeability (wheal) and neuro-mediated reflex vasodilation (flare) by the activation of histamine receptors in the skin. Firstly, we performed a control test. A drop of histamine (histamine dihydrochloride 1:1,000) was introduced in each forearm (2cm from the antecubital fossa) with a disposable lancet. After 20 minutes, the diameter of the papules and wheals formed was measured ( Figure 1 ). [9] [10] [11] In the subsequent tests, the same procedure was performed two hours after the intake of one of the commercial AH of the following brands: dexchlorpheniramine 6mg (Polaramine), hydroxyzine 25mg (Hixizine), levocetirizine 5mg (Zina), fexofenadine 180mg (Allegra), cetirizine 10mg (Zyrtec), loratadine 10mg (Claritin), ebastine 10mg (Ebastel), desloratadine 5mg (Desalex), epinastine 20mg (Talerc) and rupatadine 10mg (Rupafin), besides generic fexofenadine 180mg (Ranbaxy), loratadine 10mg (Merck) and cetirizine 10mg (Medley) ( Table 1) .
Volunteers were also questioned about possible side effects related to the medication, in particular drowsiness and dry mouth.
All tests were performed in duplicates (bilateral), in the afternoon (14h-16h), with a minimal interval of 48h so that one would not affect the other. As reference we adopted the product of the diameters of flares and wheals. The results were compared among the evaluators with a generalized linear mixed model (gamma with log link). Adherence to the probability distribution was tested by the The comparison between the frequencies of adverse effects between AH groups was tested using McNemar, chi-square and
Fisher's exact tests. 13 The concordance between the values of the forearms was calculated by the Intraclass Correlation Coefficient (ICC) for a perfect concordance.
14 The correlation between the values of flares and wheals was assessed by Spearman's correlation coefficient (rho). 13 Sample size was calculated after a pre-test with 10 volunteers in order to detect a difference of up to 5mm in the wheal of the histamine test in comparison to control.
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RESULTS
The cases were made up of seven female subjects and three male subjects, with ages between 23 and 51 years. The most commonly reported adverse effect was drowsiness, more prevalent between first generation AH (70% vs 21%; p < 0.01). Dry mouth was not significantly different between the groups (0% vs 8%; p = 0.34) ( Table 2) . When brand medications were compared to their generics, there was difference between the values of flare for fexofenadine (p < 0.01), cetirizine (p < 0.01) and loratadine (p = 0.02); however, there was no difference between the wheal values (p > 0.1) (Figure 3 ). The frequency of drowsiness and dry mouth were not different between the groups (p > 0.50) ( Table 2) .
DISCUSSION
There was a great variability in the suppression profiles of flare and wheal to the histamine test, as well as adverse effects between AH
in the dose and regime tested, and even between the volunteers, what reflects different response patterns found in clinical practice.
Other studies with slightly different methodologies confirm our results regarding the superiority of cetirizine, fexofenadine, epinastine, levocetirizine, dexchlorpheniramine and hydroxyzine in the suppression of the histamine-induced wheal. 9, 10, [16] [17] [18] [19] [20] These data do not discredit the efficacy of the other AH tested, since they effectively suppressed the wheal in comparison to control, however, our results can influence in the decision to change AH in cases of unsatisfactory control of the condition.
The triple response of Lewis, described almost a century ago, assumes that the wheal and flare formation to the histamine test are independent phenomena that depend on vascular and neurologic integrity. 21 Papules are mainly formed by interstitial edema and should correlate to the intensity of wheals and rhinitis effusion, being the most clinically relevant measurement. 10 The flare is a vasodilation phenomenon that depends on the neural reactivity and can correlate to the pruritus. In fact, there was no correlation between the diameters of the flare and the wheal for the patients in this study, The reactivity to the histamine test should not be interpreted as absolute, since the individual response can vary according to circadian rhythm, underlying infections/inflammations, room temperature, site of the test, neurologic integrity, other drugs and emotional stress levels. 22, 23 The study design using repeat measurements in both forearms, at the same time and in a homogenous group of healthy volunteers favors the internal validity of the results.
Our data add new information in Brazil regarding the potency of histamine blockage. Generics were regulated in Brazil in 1999 as drugs with proven bioequivalence in laboratories certified by ANVISA. There is a concern of the medical community that the bioequivalence of the active ingredient does not ascertain adequate bioavailability, solubility and pharmacokinetics as reference brand drugs. [25] [26] [27] [28] [29] Generic AH drugs showed some discrepancies regarding suppression potency of flares when compared to brand medications, however, there was no difference regarding wheals, what is more relevant clinically. 10 These results should raise attention for the possibility that therapeutic failures could be due to intrinsic properties of a specific generic preparation. 26, 29, 30 The study shows limitations related to the investigation of healthy individuals, single center, in a controlled situation, with only histamine challenge and a single dose of AH; this favors the internal comparison of the drugs but does not take into consideration the inflammatory and psychogenic aspects involved in histamine-dependent conditions. 8, 31, 32 There is a large variety of generic and similar AH in the Brazilian market. The choice of these manufacturers was due to the lowest price at the moment of purchase and their results do not allow generalization for other brands, which should be subsequently investigated.
Also, some AHs are known to be anti-inflammatory and act in the synthesis of leukotrienes and prostaglandins, and can have a more favorable performance in inflammatory and pruritic conditions than in this experimental comparison. 33 these results and, in addition, future comparisons should consider the association between AH, consecutive day use, variation in doses, combination with H2 and H3 receptor blockers, besides mast cell membrane stabilizers, since they are also strategies used for the treatment of refractory urticaria. 
